| Katherine A Gergen Barnett, MD | |
|
11 Melnea Cass Blvd, Boston, MA 02119-4401 | |
| (617) 414-2080 | |
| (617) 414-2090 |
| Full Name | Katherine A Gergen Barnett |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 11 Melnea Cass Blvd, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023209129 | NPI | - | NPPES |
| 110080981A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 233674 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boston Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boston University Family Medicine Inc | 0446154074 | 63 |
News Archive
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
Researchers from Klinikum Stuttgart and the University of Erlangen, Germany, report preliminary findings that show a noninvasive method of monitoring intracranial pressure (ICP) that could rival the gold standards of invasive intraventricular and intraparenchymal monitoring.
Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.
The Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, and Chester County Hospital were announced among the 2015 class of the Human Rights Campaign (HRC) Foundation's "Leader in LGBT Healthcare Equality" list, and the first to be announced in the organization's rolling admissions in 2015.
› Verified 2 days ago
| Entity Name | Boston University Family Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134166390 PECOS PAC ID: 0446154074 Enrollment ID: O20031125000010 |
News Archive
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
Researchers from Klinikum Stuttgart and the University of Erlangen, Germany, report preliminary findings that show a noninvasive method of monitoring intracranial pressure (ICP) that could rival the gold standards of invasive intraventricular and intraparenchymal monitoring.
Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.
The Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, and Chester County Hospital were announced among the 2015 class of the Human Rights Campaign (HRC) Foundation's "Leader in LGBT Healthcare Equality" list, and the first to be announced in the organization's rolling admissions in 2015.
› Verified 2 days ago
| Entity Name | South Boston Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669447413 PECOS PAC ID: 2062487291 Enrollment ID: O20040831000673 |
News Archive
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
Researchers from Klinikum Stuttgart and the University of Erlangen, Germany, report preliminary findings that show a noninvasive method of monitoring intracranial pressure (ICP) that could rival the gold standards of invasive intraventricular and intraparenchymal monitoring.
Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.
The Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, and Chester County Hospital were announced among the 2015 class of the Human Rights Campaign (HRC) Foundation's "Leader in LGBT Healthcare Equality" list, and the first to be announced in the organization's rolling admissions in 2015.
› Verified 2 days ago
| Entity Name | Boston Medical Center Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386718823 PECOS PAC ID: 0547222051 Enrollment ID: O20050531000034 |
News Archive
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
Researchers from Klinikum Stuttgart and the University of Erlangen, Germany, report preliminary findings that show a noninvasive method of monitoring intracranial pressure (ICP) that could rival the gold standards of invasive intraventricular and intraparenchymal monitoring.
Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.
The Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, and Chester County Hospital were announced among the 2015 class of the Human Rights Campaign (HRC) Foundation's "Leader in LGBT Healthcare Equality" list, and the first to be announced in the organization's rolling admissions in 2015.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine A Gergen Barnett, MD 960 Massachusetts Avenue, Fl 2, Boston, MA 02118-2690 Ph: () - | Katherine A Gergen Barnett, MD 11 Melnea Cass Blvd, Boston, MA 02119-4401 Ph: (617) 414-2080 |
News Archive
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
Researchers from Klinikum Stuttgart and the University of Erlangen, Germany, report preliminary findings that show a noninvasive method of monitoring intracranial pressure (ICP) that could rival the gold standards of invasive intraventricular and intraparenchymal monitoring.
Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.
The Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, and Chester County Hospital were announced among the 2015 class of the Human Rights Campaign (HRC) Foundation's "Leader in LGBT Healthcare Equality" list, and the first to be announced in the organization's rolling admissions in 2015.
› Verified 2 days ago
Lidya H Wlasiuk, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Yacc 5, Boston, MA 02118 Phone: 617-414-2080 Fax: 617-414-2090 | |
Brian R Penti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2080 Fax: 617-414-2090 | |
Alysia L Green, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 915 Commonwealth Ave Rear, Boston, MA 02215 Phone: 617-358-3400 Fax: 617-358-3710 | |
Shahnaz Rahman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 Harrison Ave, Boston, MA 02118 Phone: 404-259-4008 | |
Dr. Amy Min He, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 637 Washington St, Boston, MA 02124 Phone: 617-825-9660 | |
Dr. Xiangxin Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 South St, Boston, MA 02111 Phone: 617-482-7555 Fax: 617-482-2930 |